Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2007

01-10-2007

Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin

Authors: Karen Woods, James D. Douketis, Kala Kathirgamanathan, Qilong Yi, Mark A. Crowther

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2007

Login to get access

Abstract

Background

In patients who require warfarin interruption before surgery and have an elevated international normalized ratio (INR) before surgery, low-dose vitamin K may normalize the INR in time for surgery.

Patients and methods

In a retrospective cohort study, we assessed the efficacy of 1 mg oral vitamin K to normalize the INR for surgery and whether resistance to re-anticoagulation occurs when warfarin is restarted after surgery. We studied a cohort of patients with an INR 1.4–1.9 on the day before surgery who received 1 mg oral vitamin K (vitamin K group), and a comparator group of patients with a normal INR (≤1.3) on the day before surgery who did not receive vitamin K (no vitamin K group). In both patient groups, we determined the proportion of patients with a normalized INR on the day of surgery and compared the mean INR after surgery when warfarin was resumed.

Results

Of 43 patients in the vitamin K group, the INR was normalized (≤1.3) in 33 patients (76.6; 95% confidence interval [CI]: 64.1–89.4), and the INR was normal or near-normal (≤1.4) in 39 patients (90.7; 95% CI: 82.0–99.4) on the day of surgery. The mean (standard deviation) INR in the vitamin K and no vitamin K group 4–8 days after surgery was 1.75 (0.34) and 1.59 (0.36), respectively (P = 0.56).

Conclusions

In patients requiring interruption of warfarin for surgery, 1 mg oral vitamin K on the day before surgery can normalize the INR by the day of surgery and may not confer resistance to warfarin re-anticoagulation after surgery.
Literature
1.
go back to reference American Heart Association, Heart Disease and Stroke Statistics Update. 2001: Dallas, Texas American Heart Association, Heart Disease and Stroke Statistics Update. 2001: Dallas, Texas
2.
go back to reference Katholi RE, Nolan SP, McGuire LB (1976) Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 92:162–167PubMedCrossRef Katholi RE, Nolan SP, McGuire LB (1976) Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 92:162–167PubMedCrossRef
3.
go back to reference Tinker JH, Tarhan S (1978) Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA 239:738–739PubMedCrossRef Tinker JH, Tarhan S (1978) Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA 239:738–739PubMedCrossRef
4.
go back to reference Douketis JD (2002) Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 108:3–13PubMedCrossRef Douketis JD (2002) Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 108:3–13PubMedCrossRef
5.
go back to reference Spyropoulos AC, Turpie AG (2005) Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Curr Opin Pulm Med 11:373–379PubMedCrossRef Spyropoulos AC, Turpie AG (2005) Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Curr Opin Pulm Med 11:373–379PubMedCrossRef
6.
go back to reference Jaffer AK, Brotman DJ, Chukwumerije N (2003) When patients on warfarin need surgery. Cleve Clin J Med 70:973–984PubMed Jaffer AK, Brotman DJ, Chukwumerije N (2003) When patients on warfarin need surgery. Cleve Clin J Med 70:973–984PubMed
7.
go back to reference White RH, McKitrick T, Hutchison R, et al (1995) Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 122:40–42PubMed White RH, McKitrick T, Hutchison R, et al (1995) Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 122:40–42PubMed
8.
go back to reference Crowther MA, Donavan D, Harrison L, McGinnis J, Ginsberg J (1998) Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost 79:1116–1118PubMed Crowther MA, Donavan D, Harrison L, McGinnis J, Ginsberg J (1998) Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb Haemost 79:1116–1118PubMed
9.
go back to reference Patel RJ, Witt DM, Sasoon JJ, Tillman DJ, Wilkinson DS (2000) Randomized, placebo controlled trial of oral phytonadione for excessive anticoagulation. Pharmotherapy 20:1159–1166CrossRef Patel RJ, Witt DM, Sasoon JJ, Tillman DJ, Wilkinson DS (2000) Randomized, placebo controlled trial of oral phytonadione for excessive anticoagulation. Pharmotherapy 20:1159–1166CrossRef
10.
go back to reference Pengo V, Banzato A, Garelli E, Zasso A, Biasiolo A (1993) Reversal of excessive effect of regular anticoagulation: low dose of phytonadione (vitamin K1) compared with warfarin discontinuation. Blood Coagul Fibrinolysis 4:739–741PubMedCrossRef Pengo V, Banzato A, Garelli E, Zasso A, Biasiolo A (1993) Reversal of excessive effect of regular anticoagulation: low dose of phytonadione (vitamin K1) compared with warfarin discontinuation. Blood Coagul Fibrinolysis 4:739–741PubMedCrossRef
Metadata
Title
Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin
Authors
Karen Woods
James D. Douketis
Kala Kathirgamanathan
Qilong Yi
Mark A. Crowther
Publication date
01-10-2007
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2007
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0022-z

Other articles of this Issue 2/2007

Journal of Thrombosis and Thrombolysis 2/2007 Go to the issue

EditorialNotes

Focus on thrombosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine